Document is current
Any future updates will be listed below
-
Authors
Sajan, Samin A.
Gradisch, Ralph http://orcid.org/0000-0002-3312-2472
Vogel, Florian D.
Coffey, Alison J. http://orcid.org/0000-0002-1338-8513
Salyakina, Daria
Soler, Diana
Jayakar, Parul
Jayakar, Anuj
Bianconi, Simona E.
Cooper, Annina H.
Liu, Shuxi
William, Nancy http://orcid.org/0000-0002-7979-3634
Benkel-Herrenbrück, Ira
Maiwald, Robert
Heller, Corina
Biskup, Saskia
Leiz, Steffen
Westphal, Dominik S. http://orcid.org/0000-0003-4870-9863
Wagner, Matias http://orcid.org/0000-0002-4454-8823
Clarke, Amy http://orcid.org/0009-0006-1319-1311
Stockner, Thomas
Ernst, Margot
Kesari, Akanchha
Krenn, Martin http://orcid.org/0000-0003-3026-3082
- License Information
-
More Information
Article History
Received: 18 November 2023
Revised: 3 February 2024
Accepted: 19 March 2024
First Online: 2 April 2024
Competing interests
: SAS is a shareholder of Illumina, Inc. and used to be an employee for a portion of the time this study was ongoing. AJC and AK are employees and shareholders of Illumina, Inc. SL is an employee of GeneDx, LLC. RG, FDV, DS, DiSo, PJ, AJ, SEB, AHC, NW, IBH, RM, CH, SB, StLe, DSW, MW, AC, TS, ME, and MK have no conflicts of interest related to this article.
: Written informed consent for publication was obtained from all patients/legal guardians. The work adhered to the principles outlined in the Declaration of Helsinki. Additional approvals were not required, as all clinical and genetic data were derived from routine clinical diagnostic procedures.
